Search by Drug Name or NDC
NDC 50090-1831-00 BOOSTRIX 8; 2.5; 8; 5; 2.5 ug/.5mL; ug/.5mL; ug/.5mL; [iU]/.5mL; [iU]/.5mL Details
BOOSTRIX 8; 2.5; 8; 5; 2.5 ug/.5mL; ug/.5mL; ug/.5mL; [iU]/.5mL; [iU]/.5mL
BOOSTRIX is a INTRAMUSCULAR SUSPENSION in the VACCINE category. It is labeled and distributed by A-S Medication Solutions. The primary component is BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED); CLOSTRIDIUM TETANI TOXOID.
Product Information
| NDC | 50090-1831 |
|---|---|
| Product ID | 50090-1831_8e96021c-e64e-4b03-af42-52891dc7fe39 |
| Associated GPIs | 18990003221820 |
| GCN Sequence Number | 059079 |
| GCN Sequence Number Description | diphth,pertuss(acell),tet vac VIAL 2.5-8-5/.5 INTRAMUSC |
| HIC3 | W7Z |
| HIC3 Description | VACCINE/TOXOID PREPARATIONS,COMBINATIONS |
| GCN | 24618 |
| HICL Sequence Number | 006320 |
| HICL Sequence Number Description | DIPHTHERIA,PERTUSSIS(ACELLULAR),TETANUS VACCINE |
| Brand/Generic | Generic |
| Proprietary Name | BOOSTRIX |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed |
| Product Type | VACCINE |
| Dosage Form | SUSPENSION |
| Route | INTRAMUSCULAR |
| Active Ingredient Strength | 8; 2.5; 8; 5; 2.5 |
| Active Ingredient Units | ug/.5mL; ug/.5mL; ug/.5mL; [iU]/.5mL; [iU]/.5mL |
| Substance Name | BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED); CLOSTRIDIUM TETANI TOXOID |
| Labeler Name | A-S Medication Solutions |
| Pharmaceutical Class | Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Diphtheria Toxoid [CS], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordet |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA125106 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50090-1831-00 (50090183100)
| NDC Package Code | 50090-1831-0 |
|---|---|
| Billing NDC | 50090183100 |
| Package | 10 VIAL in 1 POUCH (50090-1831-0) / .5 mL in 1 VIAL (50090-1831-9) |
| Marketing Start Date | 2009-07-24 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |